Roberta D'Ambrosio

Alessio Aghemo2
Massimo Colombo2
Eleonora Grassi1
2Alessio Aghemo
2Massimo Colombo
1Eleonora Grassi
1Roberta Soffredini
Learn More
  • Alessio Aghemo, Eleonora Grassi, Maria Grazia Rumi, Roberta D'Ambrosio, Enrico Galmozzi, Elisabetta Degasperi +3 others
  • 2014
BACKGROUND Severe anemia is a common side effect of Pegylated Interferon + Ribavirin (PR) and Telaprevir (TVR) in hepatitis C virus (HCV) genotype 1 patients with advanced fibrosis or cirrhosis (F3-F4). Inosine triphosphatase (ITPA) genetic variants are associated with RBV- induced anemia and dose reduction. AIM To test the association of ITPA(More)
  • Stella De Nicola, Paola Dongiovanni, Alessio Aghemo, Cristina Cheroni, Roberta D'Ambrosio, Michele Pedrazzini +7 others
  • 2014
BACKGROUND AND AIMS The PNPLA3 I148M sequence variant favors hepatic lipid accumulation and confers susceptibility to hepatic fibrosis and hepatocellular carcinoma. The aim of this study was to estimate the effect size of homozygosity for the PNPLA3 I148M variant (148M/M) on the fibrosis progression rate (FPR) and the interaction with age at infection in(More)
  • 1